<- Go Home
CellaVision AB (publ)
CellaVision AB (publ) develops and sells instruments, software, and reagents for blood and body fluids analysis in Sweden and internationally. The company provides analyzers for microscopy systems; and DIFF-Line, a hematology lab that handles a smaller amount daily blood samples, as well as consists of three instruments, such as CellaVision DC-1, RAL SmearBox, and RAL StainBox for smearing, staining, and analyzing peripheral blood smears. It also provides CellaVision DC-1 for performing blood cell differentials; and CellaVision DM1200 and CellaVision DM9600 to automate and simplify the process of performing blood and body fluid differentials. In addition, the company’s CellaVision Bone Marrow Aspirate Application enables laboratories to automate, standardize, and simplify morphological examination of bone marrow aspirate samples; CellaVision Peripheral Blood Application enables laboratories to automate, standardize and simplify morphological examination like peripheral blood smears; CellaVision Advanced RBC Application performs a more comprehensive examination for red blood cell morphology; CellaVision Body Fluid Application is for examination body fluid preparations; CellaVision CellAtlas, a library of blood cell images and descriptions created by digital cell morphology experts; CellaVision Review Software removes restrictive constraints from smear review process and performs better; CellaVision Server Software creates a single streamlined workflow within one or multiple testing sites; and CellaVision VET is a veterinary lab. It sells its products to hospitals and commercial laboratories. The company was incorporated in 1994 and is based in Lund, Sweden.
Market Cap
SEK 3.1B
Volume
26.6K
Cash and Equivalents
SEK 230.2M
EBITDA
SEK 194.1M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
SEK 496.7M
Profit Margin
67.98%
52 Week High
SEK 202.50
52 Week Low
SEK 117.60
Dividend
2.14%
Price / Book Value
3.35
Price / Earnings
22.84
Price / Tangible Book Value
4.30
Enterprise Value
SEK 2.9B
Enterprise Value / EBITDA
13.83
Operating Income
SEK 173.5M
Return on Equity
15.30%
Return on Assets
9.95
Cash and Short Term Investments
SEK 230.2M
Debt
SEK 22.4M
Equity
SEK 914.3M
Revenue
SEK 730.6M
Unlevered FCF
SEK 89.9M
Sector
Health Care Equipment and Supplies
Category
N/A